The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

Geographically, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.

The global market is projected to reach USD 36.6 billion by 2021 from USD 25.1 billion in 2016, at a CAGR of 7.9% during the forecast period. This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations. Moreover, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for immunoassay techniques further provide significant growth opportunities for market players in the women health diagnostics market. However, high cost of diagnostic imaging systems & procedures and shortage of skilled laboratory technicians are the major factors hampering the growth of this market.

The global market has been segmented, on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end user, the global women health diagnostics is segmented into three segments, namely, hospital and clinics, home healthcare, and diagnostic & imaging centers.

In 2015, the breast cancer testing segment accounted for the largest share of the market. However, the prenatal genetic screening and carrier testing segment is expected to grow at a higher CAGR during the forecast period. This growth can be attributed to factors such as the growing number of doctors offering genetic screening tests to pregnant women and growing awareness about these tests.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. Asia-Pacific represented the fastest-growing region for the women health diagnostics market during the forecast period, primarily due to improving healthcare infrastructure, growing per capita income, growing awareness among women regarding various health disorders, and rising focus of key market players on this region.

The global women health diagnostics market is a mature market and characterized by the presence of number of players. This industry is witnessing an increasing number of acquisitions, product launches and alliances such as partnerships, agreements, and collaborations between players offering better women health diagnostics solutions.

Market Dynamics

Drivers

High prevalence of infectious disease in women

Rising incidences of chronic and lifestyle-related disorders in women

Increasing awareness about fertility testing in women and initiatives taken by government and health organizations

Increasing adoption of point-of-care and rapid diagnostic tests

Growth in the number of private diagnostic and imaging centers

Public-private partnerships to enhance the infrastructure of diagnostic imaging centers

Restraints

High cost of diagnostic imaging systems and procedures

Shortage of skilled laboratory technicians

Opportunities

Improving healthcare infrastructure in emerging markets

Growing number of regulatory approvals for immunoassay diagnostic techniques

Challenges

Stringent regulatory guidelines

Increasing adoption of refurbished diagnostic imaging systems

Key Questions

Currently, which are major applications in women’s health diagnostics market and which will be the emerging applications in the near future?

What are the major end users in market?

Most of the vendors have opted product launches, agreements, collaborations, & partnerships, and acquisitions as the key growth strategies. Where will it take the industry in the mid to long term in terms of innovation and market growth?

What are the growth strategies and strengths of market players impacting their market positioning?